
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701. BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.9902 | -41.4625 | 4.8 | 4.8816 | 2.51 | 3773183 | 3.2930998 | CS |
4 | -2.8974 | -50.76745164 | 5.7072 | 6.992 | 2.51 | 3636401 | 4.81026945 | CS |
12 | -6.1582 | -68.6685994648 | 8.968 | 9.6176 | 2.51 | 1960264 | 5.65695999 | CS |
26 | -9.0302 | -76.2685810811 | 11.84 | 13.3616 | 2.51 | 1117132 | 6.68960747 | CS |
52 | -35.5902 | -92.6828125 | 38.4 | 61.12 | 2.51 | 1035392 | 20.63102735 | CS |
156 | -282.1502 | -99.0139668725 | 284.96 | 546 | 2.51 | 1124078 | 108.33655756 | CS |
260 | -341.3502 | -99.1835774059 | 344.16 | 1198.24 | 2.51 | 860121 | 223.98286865 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約